Skip to main content
Caplight Logo









FOx Biosystems

FOx Biosystems

Private
DiepenbeekHealthcare & Life Scienceshttps://foxbiosystems.com/

Last Round

Grant

Dec 19, 2022

Total Funding Raised

$7.22M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

FOx Biosystems is a life sciences company that provides instruments, sensor probes, and services based on its fiber-optic surface plasmon resonance (FO-SPR) biosensor technology for real-time, label-free analysis.

Sector

Healthcare & Life Sciences

Verticals

Biotech Equipment, Biotechnology, Drug Discovery, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

fiber-optic surface plasmon resonanceFO-SPRbiomolecular interaction analysissurface plasmon resonanceSPRfluidics-free biosensorlabel-free analysisBIAbiosensor instrumentcrude sample analysisdrug discovery toolskinetic analysisbioprocessing analyticsprotein quantificationaffinity measurementanalytical services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

FOx Biosystems Comparables

Compare FOx Biosystems with similar companies based on industry and business-model similarity.

FOx Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Gator Bio
85%
Affinité Instruments
83%
XanTec bioanalytics GmbH
82%

FOx Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 19, 2022
Series AFeb 19, 2019

FOx Biosystems Investors

Notable investors and investment history

FOx Biosystems investors
InvestorRounds
LRMSeries A
European Innovation CouncilGrant
HERAN PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 20, 2026

    Open roles increased from 0 to 12, representing 133% of headcount.

  • Oct 13, 2025

    Grew 43% QoQ, from 7 to 10 employees.

FOx Biosystems Filings

Explore SEC and related filing metadata, where available.

FOx Biosystems filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about FOx Biosystems's valuation, stock price, and market status.

Is FOx Biosystems a public or private company?

FOx Biosystems is a private company.

What is the current stock price of FOx Biosystems?

FOx Biosystems is a private company with no public stock price. No recent secondary market data is available.

How much is FOx Biosystems worth (valuation)?

Valuation information for FOx Biosystems is not publicly available.

Can I buy FOx Biosystems stock?

FOx Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was FOx Biosystems's last funding round?

Funding round information for FOx Biosystems is not publicly available.

Who are the main investors in FOx Biosystems?

Investor information for FOx Biosystems is not publicly disclosed.

Will FOx Biosystems IPO soon?

No public IPO plans have been announced for FOx Biosystems.

How can I track FOx Biosystems secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor FOx Biosystems's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDiepenbeek
Employee Range9
Year Founded2017
Last FundingDec 19, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?